Compensatory Paraoxonase and Arylesterase Levels in Hyperbaric Oxygen Treatment of Sudden Sensorineural Hearing Loss

Compensatory Paraoxonase and Arylesterase Levels in Hyperbaric Oxygen Treatment of Sudden Sensorineural Hearing Loss

Objective: Paraoxonase1 (PON1) and Arylesterase (ARE) levels are associated with reduced risk of atherosclerosis. The functional status of high density lipoprotein (HDL) is closely related to the PON1/ARE enzyme activity. Functional changes in treatment of sudden sensorineural hearing loss (SSNHL) m...

Full description

Bibliographic Details
Main Authors: Eren Esin, Yilmaz Necat, Yildirim Furkan, Giray Ozlem
Format: Article
Language:English
Published: Sciendo 2020-03-01
Series:Polish Hyperbaric Research
Subjects:
paraoxonase
hyperbaric oxygen therapy
inflammation
oxidative stress
reactive oxygen species arylesterase
Online Access:https://doi.org/10.2478/phr-2020-0004
Description
Summary:Objective: Paraoxonase1 (PON1) and Arylesterase (ARE) levels are associated with reduced risk of atherosclerosis. The functional status of high density lipoprotein (HDL) is closely related to the PON1/ARE enzyme activity. Functional changes in treatment of sudden sensorineural hearing loss (SSNHL) may be achieved by post-translational modification of lipid metabolism induced by hyperbaric oxygen therapy (HBOT).
ISSN:2084-0535

Similar Items